|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
15.800 +0.100 (+0.637%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 231,981,300 | 7.486% | 215,824,259 | 191,909,156 | 186,565,796 | 159,084,397 | |
| Cost of Sales | -- | -- | -- | -- | -- | (137,390,362) | |
| Gross Profit | -- | -- | -- | -- | -- | 21,694,035 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (425,194) | 22.971% | (345,767) | (742,161) | (1,182,031) | (717,012) | |
| Profit / (Loss) on Disposal | 1,438,918 | 2368.580% | 58,289 | 52,149 | 71,336 | 600,608 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 526,743 | -33.290% | 789,596 | 1,009,547 | 765,186 | 647,711 | |
| Profit / (Loss) before Taxation | 8,808,353 | 8.160% | 8,143,815 | 7,175,483 | 6,262,467 | 5,343,378 | |
| Taxation | (1,816,339) | -2.830% | (1,869,245) | (1,570,219) | (1,431,725) | (887,117) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,374,863) | 16.405% | (1,181,102) | (1,109,047) | (749,748) | (575,198) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 5,617,152 | 10.281% | 5,093,467 | 4,496,217 | 4,080,994 | 3,881,063 | |
| Net Finance Costs / (Income) | 1,313,192 | 5.446% | 1,245,369 | 1,239,584 | 1,258,772 | 809,415 | |
| Depreciation & Amortisation | 2,417,627 | 3.908% | 2,326,697 | 2,298,453 | 2,019,827 | 1,302,205 | |
| Directors' Emoluments | 20,595 | 4.263% | 19,753 | 18,111 | 19,484 | 12,315 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 161.000 | -- | 179.000 | 158.000 | 144.000 | 137.000 |
| DPS (cts) | 61.000 | -- | 42.000 | 48.000 | 44.000 | 41.000 |
| Dividend Payout Ratio (%) | 37.888% | -- | 23.464% | 30.380% | 30.556% | 29.927% |
| Cash flow per share ($) | 1.362 | -- | 1.781 | 2.408 | 2.119 | 0.564 |
| NBV per share ($) | 18.137 | -- | 17.367 | 15.958 | 14.658 | 13.727 |
| Remarks: | Real time quote last updated: 09/06/2023 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,617,152 |
| %Change | 10.281% |
| EPS / (LPS) | RMB 1.610 |
| NBV Per Share (¥) | RMB 18.137 |